CTLA4 and colonic neoplasm: In addition, a recent study showed that AMPK induced by a KD enhanced the efficacy of anti-CTLA-4 immunotherapy by decreasing PD-L1 and increasing the expression of type-1 IFN and antigen presenting genes in breast and colon cancer cells [177].